PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 163 filers reported holding PDL BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $536,000 | +8.3% | 170,156 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $495,000 | +3.1% | 170,156 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $480,000 | -15.8% | 170,156 | -3.1% | 0.00% | 0.0% |
| Q4 2019 | $570,000 | +50.4% | 175,552 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $379,000 | -34.1% | 175,552 | -4.2% | 0.00% | 0.0% |
| Q2 2019 | $575,000 | -29.6% | 183,256 | -16.5% | 0.00% | -50.0% |
| Q1 2019 | $817,000 | +24.4% | 219,498 | -3.2% | 0.00% | +100.0% |
| Q4 2018 | $657,000 | +14.5% | 226,684 | +3.9% | 0.00% | 0.0% |
| Q3 2018 | $574,000 | +7.9% | 218,110 | -4.0% | 0.00% | 0.0% |
| Q2 2018 | $532,000 | -22.1% | 227,305 | -2.1% | 0.00% | 0.0% |
| Q1 2018 | $683,000 | +0.1% | 232,204 | -6.8% | 0.00% | 0.0% |
| Q4 2017 | $682,000 | -20.9% | 249,048 | -2.1% | 0.00% | -50.0% |
| Q3 2017 | $862,000 | +23.9% | 254,338 | -9.7% | 0.00% | +100.0% |
| Q2 2017 | $696,000 | -5.8% | 281,776 | -13.4% | 0.00% | 0.0% |
| Q1 2017 | $739,000 | +2.5% | 325,376 | -4.3% | 0.00% | 0.0% |
| Q4 2016 | $721,000 | -38.5% | 340,076 | -2.8% | 0.00% | -50.0% |
| Q3 2016 | $1,172,000 | +7.7% | 349,876 | +1.0% | 0.00% | 0.0% |
| Q2 2016 | $1,088,000 | -6.0% | 346,476 | -0.3% | 0.00% | 0.0% |
| Q1 2016 | $1,157,000 | +7.5% | 347,554 | +14.3% | 0.00% | -33.3% |
| Q4 2015 | $1,076,000 | -28.4% | 304,070 | +1.8% | 0.00% | -25.0% |
| Q3 2015 | $1,502,000 | -22.1% | 298,693 | -0.3% | 0.00% | -20.0% |
| Q2 2015 | $1,927,000 | -7.0% | 299,693 | +1.8% | 0.01% | 0.0% |
| Q1 2015 | $2,071,000 | -10.3% | 294,319 | -1.7% | 0.01% | 0.0% |
| Q4 2014 | $2,308,000 | +4.2% | 299,319 | +1.0% | 0.01% | 0.0% |
| Q3 2014 | $2,214,000 | -22.0% | 296,452 | +1.1% | 0.01% | -28.6% |
| Q2 2014 | $2,838,000 | +17.1% | 293,169 | +0.5% | 0.01% | +16.7% |
| Q1 2014 | $2,424,000 | +13.4% | 291,669 | +15.1% | 0.01% | 0.0% |
| Q4 2013 | $2,138,000 | +6.5% | 253,369 | +0.6% | 0.01% | 0.0% |
| Q3 2013 | $2,007,000 | +6.6% | 251,769 | +3.2% | 0.01% | 0.0% |
| Q2 2013 | $1,883,000 | +5.9% | 243,954 | +0.3% | 0.01% | 0.0% |
| Q1 2013 | $1,778,000 | – | 243,224 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |